<DOC>
	<DOCNO>NCT01856114</DOCNO>
	<brief_summary>The goal clinical research study learn fentanyl change perception shortness breath cancer patient . Researchers also want learn study drug help improve physical function . In study , fentanyl compare placebo . Fentanyl commonly use treatment cancer pain . A placebo drug . It look like study drug design treat disease illness . It design compare study drug learn study drug real effect .</brief_summary>
	<brief_title>Fentanyl Buccal Tablets Exercise Induced Breakthrough Dyspnea</brief_title>
	<detailed_description>Study Groups : If find eligible take part study , randomly assign ( flip coin ) either receive fentanyl placebo . You equal chance assign either group . Neither study staff know receive study drug placebo . However , need safety , study staff able find receiving . Study Visit : During study visit , study staff collect information medical record age , sex , race , disease type , well able perform normal activity daily live , drug take , possible cause shortness breath . You complete 2 questionnaire . One ( 1 ) question breathe symptom may , ask symptom may . It take 10 minute complete questionnaire . The study staff record vital sign ( heart rate , breathe rate , level air breathe use measure device clip onto finger ) . You also ask hard catch breath rate level tiredness . You walk back forth indoor corridor 6 minute . This call walk test . You may slow , stop , rest time need . After , sit rest 1 hour . During time , study drug/placebo prepare may ask several time hard catch breath . You give study drug/placebo tablet put upper gum cheek . You wait another 30 minute , ask side effect may , repeat walk test . Then study staff ask side effect may , level tiredness , hard catch breath . Your vital sign also measure . During walk test , ask 6 time hard catch breath . How often stop long record . The total distance walk also record . After walk test , also ask complete 4 test mental ability , include finger tapping , simple mathematics question ( addition , subtraction , multiplication , division ) , recall number , recall object . It take 15 minute complete test . At end study visit , fill 1 questionnaire asks think study drug/placebo help , satisfied study , treatment think receive . It take 5 minute complete questionnaire . Length Study : Your active participation study complete last questionnaire . You take study intolerable side effect occur unable follow study direction . Follow-Up : Thirty ( 30 ) day study visit call study staff ask feeling side effect may . This call last 10 minute . This investigational study . Fentanyl FDA approve commercially available treatment pain . Its use control shortness breath investigational . Up 20 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Dyspnea</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>1 . Diagnosis cancer evidence active disease 2 . Breakthrough dyspnea , define study dyspnea exertion average intensity level &gt; /=3/10 numeric rating scale 3 . Outpatient MD Anderson Cancer Center see Supportive Care Service , Thoracic Medical Oncology Cardiopulmonary Center 4 . Ambulatory able walk without walk aid 5 . On strong opioids morphine equivalent daily dose 60130 mg least one week , stable ( i.e . +/ 30 % ) regular dose last 24 hour 6 . Karnofsky performance status &gt; /=50 % 7 . Age 18 old 8 . Able complete study assessment 9 . Must speak understand English . 1 . Dyspnea rest &gt; /=7/10 time enrollment 2 . Supplemental oxygen requirement &gt; 6 L per minute 3 . Delirium ( i.e . Memorial delirium rating scale &gt; 13 ) 4 . History unstable angina myocardial infarction 1 month prior study enrollment 5 . Resting heart rate &gt; 120 time study enrollment 6 . Systolic pressure &gt; 180 mmHg diastolic pressure &gt; 100 mmHg time study enrollment 7 . History active opioid abuse within past 12 month 8 . History allergy fentanyl 9 . Severe anemia ( Hb &lt; 7g/L ) document last month correct prior study enrollment* 10 . Bilirubin &gt; 5X Upper limit normal document last month lower &lt; 5x normal prior study enrollment* 11 . Diagnosis acute pulmonary embolism within past 2 week 12 . Diagnosis pulmonary hypertension 13 . Unwilling provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Advanced Cancers</keyword>
	<keyword>Cancer evidence active disease</keyword>
	<keyword>Exercise induce breakthrough dyspnea</keyword>
	<keyword>Shortness breath</keyword>
	<keyword>Fentanyl Buccal Tablets</keyword>
	<keyword>FBT</keyword>
	<keyword>Placebo</keyword>
	<keyword>Walk test</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
</DOC>